ruled that donald trump s role injan 6th riot at the us capitol meant he was ineligible to run for office again. the ruling referred to clause 3 of the 14th amendment of the us constitution that prohibits anyone who has engaged in insurrection or rebellion from holding elected office. the supreme court has since taken up that case. and before them in support of colorado is a brief signed by twenty five historians, all of them experts on the civil war and reconstruction. in their submission they write, that, contemporary evidence from the decision makers who sponsored, backed, and voted for the 14th amendment, demonstrates that decision makers crafted section three to cover the president and to create an enduring check on insurrection, requiring no additional action from congress. there are diverging legal views on whether trump must actually be found guilty of the crime of insurrection before he can be deemed constitutionally ineligible, and whether congress needs to play a r
the neurotransmitters in just one site in the brain. and it re circuits the motor signals and allows the patients to move normally. so it s an innovative way of using gene therapy, which involves local delivery of the gene that makes a signal and then changes how the brain processes in order to help with the symptoms of disease. it s important to note that this kind of gene therapy isn t yet a solution for everyone, and it does still have limitations. challenges still remain in manufacturing the genetic material and reducing side effects. and of course, there may be significant implications around cost. but the work being done by meiragtx and other medical companies has the potential, at least, to change lives.
control their motor symptoms. rather than putting electrodes into the brain, we re able to put a tiny dose of a very specific gene that changes the neurotransmitters in just one site in the brain. and it re circuits the motor signals and allows the patients to move normally. so it s an innovative way of using gene therapy, which involves local delivery of the gene that makes a signal and then changes how the brain processes in order to help with the symptoms of disease. it s important to note that this kind of gene therapy isn t yet a solution for everyone, and it does still have limitations. challenges still remain in manufacturing the genetic material and reducing side effects. and, of course, there may be
a tiny dose of a very specific gene that changes the neurotransmitters in just one site in the brain. and it re circuits the motor signals and allows the patients to move normally. so it s an innovative way of using gene therapy, which involves local delivery of the gene that makes a signal and then changes how the brain processes in order to help with the symptoms of disease. it s important to note that this kind of gene therapy isn t yet a solution for everyone, and it does still have limitations. challenges still remain in manufacturing the genetic material and reducing side effects. and of course, there may be significant implications around cost.
the neurotransmitters in just one site in the brain. and it re circuits the motor signals and allows the patients to move normally. so it s an innovative way of using gene therapy, which involves local delivery of the gene that makes a signal and then changes how the brain processes in order to help with the symptoms of disease. it s important to note that this kind of gene therapy isn t yet a solution for everyone, and it does still have limitations. challenges still remain in manufacturing the genetic material and reducing side effects. and of course, there may be significant implications around cost. but the work being done by meiragtx and other medical companies has the potential, at least, to change lives. that was paul. one of my best friends has been